![Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics](https://pubs.rsna.org/cms/10.1148/rg.2021210005/asset/images/medium/rg.2021210005.va.gif)
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
![Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours | Nature Reviews Urology Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours | Nature Reviews Urology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41585-020-0296-x/MediaObjects/41585_2020_296_Fig1_HTML.png)
Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours | Nature Reviews Urology
![BRCA1 regulation on β-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer | Oncogenesis BRCA1 regulation on β-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer | Oncogenesis](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Foncsis.2017.75/MediaObjects/41389_2017_Article_BFoncsis201775_Fig1_HTML.jpg)
BRCA1 regulation on β-hCG: a mechanism for tumorigenicity in BRCA1 defective breast cancer | Oncogenesis
![Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study | Journal of Clinical Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study | Journal of Clinical](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2015/jco.2015.61.33.issue-22/jco.2014.59.5132/20161107/images/medium/zlj02215-5342-t02.jpeg)
Phase II Trial Assessing the Ability of Neoadjuvant Chemotherapy With or Without Second-Look Surgery to Eliminate Measurable Disease for Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study | Journal of Clinical
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
Determining an Optimal Cutoff of Serum β-Human Chorionic Gonadotropin for Assisting the Diagnosis of Intracranial Germinomas | PLOS ONE
![Progesterone limits the tumor-promoting effects of the beta-subunit of human chorionic gonadotropin via non-nuclear receptors - ScienceDirect Progesterone limits the tumor-promoting effects of the beta-subunit of human chorionic gonadotropin via non-nuclear receptors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004222007982-fx1.jpg)
Progesterone limits the tumor-promoting effects of the beta-subunit of human chorionic gonadotropin via non-nuclear receptors - ScienceDirect
![An update on the clinical diagnostic value of β-hCG and αFP for intracranial germ cell tumors | European Journal of Medical Research | Full Text An update on the clinical diagnostic value of β-hCG and αFP for intracranial germ cell tumors | European Journal of Medical Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs40001-016-0204-2/MediaObjects/40001_2016_204_Fig1_HTML.gif)